Use of Endocrine Therapy for Breast Cancer Risk Reduction
- 8 pages
- Spiral Bound
- 80# Aqueous Coating
- 4.25" x 7.25"
- Ships in 5 – 10 business days
- Key Points
- Tables
- Breast Cancer Risk Assessment Tools
- Summary of All Recommendations
- Summary of Agent Indications
- Adverse Effects of Endocrine Therapy
- For purchases under 100 in quantity, we suggest placing the order directly through the website.
- We offer group/institutional licenses for multi-user accounts (discount amount varies depending on the number of users).
- We are proud to offer special discounts to medical schools, training programs, students and more.
- We offer bulk purchase discounts based on number of copies and number of titles.
Contact Us for more details
Description
This pocket guide is derived from recommendations in the American Society of Clinical Oncology Guideline. This resource is a practice tool based on ASCO® practice guidelines and is not intended to substitute for the independent professional judgment of the treating physician. Practice guidelines do not account for individual variation among patients. This pocket guide does not purport to suggest any particular course of medical treatment. Use of the practice guidelines and this resource are voluntary. The practice guidelines and additional information are available at www.asco.org/supportive-care-guidelines. Copyright © 2021 by American Society of Clinical Oncology. All rights reserved.
You can also find this product included in this bundle!
![](https://www.guidelinecentral.com/wp-content/uploads/2021/12/ASCO-Bundle-Website-300x512.png)
- Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer
- Adjuvant Therapy for Stage III Colon Cancer
- Advanced Gastroesophageal Cancer
- Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
- Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer – Brain Metastases
- Antiemetics
- Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression
- Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology
- Anxiety and Depression in Adult Survivors of Cancer
- Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer
- Axilla Management in Early-Stage Breast Cancer
- Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer
- Biomarkers for Systemic Therapy in Metastatic Breast Cancer
- Bone-Modifying Agents in Metastatic Breast Cancer
- Bone-Modifying Agents in Multiple Myeloma
- Breast Cancer Germline Testing
- Cancer Survivorship for People Affected by Advanced or Metastatic Cancer
- Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents
- Cannabis in Adults with Cancer
- Cardiac Dysfunction - Prevention and Monitoring in Cancer Survivors
- Cervical Cancer Prevention
- Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma
- Chemotherapy-Naïve Castration-Resistant Prostate Cancer
- Chronic Pain in Survivors of Adult Cancers
- Clear Cell Renal Cell Carcinoma
- Colorectal Cancer Biomarkers
- Colorectal Cancer Early Detection
- Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck
- Diffuse Astrocytic and Oligodendroglial Tumors in Adults
- Early-Stage Breast Cancer
- Estrogen and Progesterone Receptor Testing in Breast Cancer
- Exercise, Diet, and Weight Management During Cancer Treatment
- Fatigue in Adult Survivors of Cancer
- Fertility Preservation
- Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer
- Germline Genetic Testing for Cancer
- Hepatitis B Virus Screening and Management for Patients with Cancer Prior to Therapy
- HER2 Testing in Breast Cancer
- Hormone Receptor–Positive Breast Cancer Adjuvant Endocrine Therapy
- HR-Positive, HER2-Negative Metastatic Breast Cancer
- Immune-related Adverse Events from Immune Checkpoint Inhibitor Therapy
- Immune-related Adverse Events — CAR T-Cell Therapy
- Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer
- Integrative Medicine for Pain Management in Oncology
- Integrative Oncology Care of Symptoms of Anxiety and Depression in Adult Patients with Cancer
- Invasive Cervical Cancer
- Laryngeal Cancer
- Late-Stage Colorectal Cancer
- Locally Advanced Rectal Cancer
- Lung Cancer Surveillance After Definitive Curative-Intent Therapy
- Malignant Pleural Mesothelioma
- Management of Cancer Cachexia
- Management of Dyspnea in Advanced Cancer
- Management of Hereditary Breast Cancer
- Management of Male Breast Cancer
- Management of Osteoporosis
- Management of Salivary Gland Malignancy
- Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx
- Medication-Related Osteonecrosis of the Jaw
- Metastatic Colorectal Cancer
- Metastatic HER2-Negative Breast Cancer – Chemo- and Targeted Therapy
- Metastatic Pancreatic Cancer
- Metastatic Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors
- Molecular Biomarkers in Localized Prostate Cancer
- Multiple Myeloma
- Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer
- Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer
- Non-Small Cell Lung Cancer — Adjuvant Therapy for Completely Resected Stages I-IIIA
- Optimum Imaging Strategies for Advanced Prostate Cancer
- Osteoradionecrosis in Patients With Head and Neck Cancer
- Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy
- Ovarian Masses and Treatment of Epithelial Ovarian Cancer
- Palliative Care
- Palliative Care in the Global Setting
- Pancreatic Cancer - Evaluating Susceptibility
- PARP Inhibitors in the Management of Ovarian Cancer
- Penile Cancer
- Platelet Transfusion
- Potentially Curable Pancreatic Adenocarcinoma
- Prevention And Management Of Chemotherapy-Induced Peripheral Neuropathy In Survivors Of Adult Cancers
- Recurrent and Metastatic Head and Neck Cancers
- Salivary Gland Hypofunction and/or Xerostomia
- Secondary Prevention of Cervical Cancer
- Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer
- Small Renal Masses
- Somatic Genomic Testing for Metastatic or Advanced Cancer
- Stage II Colon Cancer Adjuvant Therapy
- Stage III Non-Small Cell Lung Cancer
- Stage IV Non-Small Cell Lung Cancer without Driver Alterations
- Systemic Therapy for Advanced Hepatocellular Carcinoma
- Systemic Therapy for Melanoma
- Systemic Therapy for Small Cell Lung Cancer
- Systemic Treatment of Patients With Metastatic Breast Cancer
- Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations
- Treatment for Brain Metastases
- Treatment of Early-Stage Colorectal Cancer
- Treatment of Locally Advanced Esophageal Carcinoma
- Treatment of Metastatic Carcinoma and Myeloma of the Femur
- Use of Endocrine Therapy for Breast Cancer Risk Reduction
- Use of Opioids for Cancer Pain
- Vaccination of Adults with Cancer
- Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer
- Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy
- White Blood Cell Growth Factors
Related Guidelines
![](https://www.guidelinecentral.com/wp-content/uploads/2023/07/ASCO-NSCLC-Stage-III-2024-v5a-cover-800px.png)
Stage III Non-Small Cell Lung Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2024/02/NSCLC-Stage-IV-with-Drivers-ASCO-2024-v3-cover-800px.png)
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations
![](https://www.guidelinecentral.com/wp-content/uploads/2024/05/ASCO-RX-Standards-2024-v2a-052024-cover-800px.png)
Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology
![](https://www.guidelinecentral.com/wp-content/uploads/2021/12/ASCO-Early-Breast-Ca-2024-v5b-cover-800px.png)
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2024/05/ASCO-Genetic-Cancer-Testing-2024-cover-800px.png)
Germline Genetic Testing for Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2024/05/ASCO-Cancer-Fatigue-2024-cover-800px.png)
Fatigue in Adult Survivors of Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2024/05/HR_-Burstein-ASCO-2025-v5b-cover-800px.png)
HR-Positive, HER2-Negative Metastatic Breast Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2024/05/ASCO-Breast-Biomarkers-Henry-2024-v5b-cover-800px.png)
Biomarkers for Systemic Therapy in Metastatic Breast Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2024/04/ASCO-ORN-2024-cover-800px.png)
Osteoradionecrosis in Patients With Head and Neck Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2024/04/ASCO-Cancer-Survivorship-2024-cover-800px.png)
Cancer Survivorship for People Affected by Advanced or Metastatic Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2020/11/ASCO-HCC-Rx-2024-cover-800px.png)
Systemic Therapy for Advanced Hepatocellular Carcinoma
![](https://www.guidelinecentral.com/wp-content/uploads/2024/02/NSCLC-Stage-IV-wo-Drivers-ASCO-2024-v3-cover-800px.png)
Stage IV Non-Small Cell Lung Cancer without Driver Alterations
![](https://www.guidelinecentral.com/wp-content/uploads/2024/01/ASCO-Metastatic-Breast-Cancer-cover-800px.png)
Systemic Treatment of Patients With Metastatic Breast Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2024/01/ASCO-Breast-Germline-2023-cover-800px.png)
Breast Cancer Germline Testing
![](https://www.guidelinecentral.com/wp-content/uploads/2023/10/ASCO-SCLC-2023-v2-cover.jpg)
Systemic Therapy for Small Cell Lung Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2023/09/ASCO-NETs-2023-v3a-cover-800px.png)
Metastatic Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors
![](https://www.guidelinecentral.com/wp-content/uploads/2023/08/ASCO-Integrative-Anxiety-Depression-cover-800px.png)
Integrative Oncology Care of Symptoms of Anxiety and Depression in Adult Patients with Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2023/07/ASCO-Vulnerable-Older-2023-cover-800px.png)
Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy
![](https://www.guidelinecentral.com/wp-content/uploads/2018/05/ASCO-HER2-Testing-cover-800px-300x471.png)
HER2 Testing in Breast Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2019/08/ASCO-VTE-Prophy-cover-800px-300x512.png)
Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2023/04/ASCO-Anxiety-Depression-2023-cover-800px.png)
Anxiety and Depression in Adult Survivors of Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2021/01/ASCO-Non-Castrate-Prostate-Ca-Update-2023-cover-800px.png)
Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2023/03/EAU-ASCO-Penile-Ca-2023-cover-800px.png)
Penile Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2021/07/HR-Moy-ASCO-2022-v4b-cover-800px.png)
Metastatic HER2-Negative Breast Cancer – Chemo- and Targeted Therapy
![](https://www.guidelinecentral.com/wp-content/uploads/2020/08/ASCO-PARPi-cover-800px-300x512.png)
PARP Inhibitors in the Management of Ovarian Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2022/12/ASCO-Immuno-HNSCC-cover-800px.png)
Recurrent and Metastatic Head and Neck Cancers
![](https://www.guidelinecentral.com/wp-content/uploads/2022/10/ASCO-Cervical-Cancer-2022-cover-800px.png)
Secondary Prevention of Cervical Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2022/09/Integrative-Pain-ASCO-2022-v3-cover-800px.png)
Integrative Medicine for Pain Management in Oncology
![](https://www.guidelinecentral.com/wp-content/uploads/2022/05/ASCO-HER2-Advanced-Brain-Ramakrishna-2022-cover-300x512.jpg)
Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer – Brain Metastases
![](https://www.guidelinecentral.com/wp-content/uploads/2022/05/ASCO-HER2-Advanced-Giordano-2022-cover-800px-300x512.png)
Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2022/05/ASCO-Diet-Exercise-2022-cover-800px-300x512.png)
Exercise, Diet, and Weight Management During Cancer Treatment
![](https://www.guidelinecentral.com/wp-content/uploads/2019/05/ASCO-Breast-Ca-Biomarkers-2022-v4b-cover-800px-300x471.png)
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2021/12/ASCO-Neoadj-Breast-Cancer-cover-800px-300x512.png)
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2022/02/ASCO-NSCLC-I-IIIA-2022-cover-800px-300x512.png)
Non-Small Cell Lung Cancer — Adjuvant Therapy for Completely Resected Stages I-IIIA
![](https://www.guidelinecentral.com/wp-content/uploads/2022/02/ASCO-Somatic-Genomic-Testing-cover-800px-300x471.png)
Somatic Genomic Testing for Metastatic or Advanced Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2022/01/ASCO-Bone-Breast-2021-cover-800px-300x512.png)
Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2021/12/ASCO-Stage-II-Colon-cover-800px-300x512.png)
Stage II Colon Cancer Adjuvant Therapy
![ASCO Treatment for Brain Metastases Guidelines Pocket Guide Cover](https://www.guidelinecentral.com/wp-content/uploads/2021/12/ASCO-Brain-Mets-2021-v2a-cover-800px-300x512.png)
Treatment for Brain Metastases
![](https://www.guidelinecentral.com/wp-content/uploads/2021/12/ASCO-Oligodendroglial-Tumors-2021-v3-cover-800px-300x512.png)
Diffuse Astrocytic and Oligodendroglial Tumors in Adults
![](https://www.guidelinecentral.com/wp-content/uploads/2020/07/ASCO-HBV-cover800px-300x512.png)
Hepatitis B Virus Screening and Management for Patients with Cancer Prior to Therapy
![](https://www.guidelinecentral.com/wp-content/uploads/2021/11/ASCO-irAE-ICPi-2021-cover-800px-300x471.png)
Immune-related Adverse Events from Immune Checkpoint Inhibitor Therapy
![](https://www.guidelinecentral.com/wp-content/uploads/2021/11/ASCO-irAE-CAR-T-2021-cover-800px-300x471.png)
Immune-related Adverse Events — CAR T-Cell Therapy
![](https://www.guidelinecentral.com/wp-content/uploads/2020/06/ASCO-Esophageal-Local-2021-v4a-800px-300x512.png)
Treatment of Locally Advanced Esophageal Carcinoma
![](https://www.guidelinecentral.com/wp-content/uploads/2021/06/Ovarian-Masses-ASCO-2021-v3a-cover-800px-300x471.png)
Ovarian Masses and Treatment of Epithelial Ovarian Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2020/04/ASCO-Hereditary-Brst-Ca-2021-cover-800px-300x512.png)
Management of Hereditary Breast Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2021/07/ASCO-Salivary-Gland-Hypofunction-cover-800px-300x512.png)
Salivary Gland Hypofunction and/or Xerostomia
![](https://www.guidelinecentral.com/wp-content/uploads/2021/07/Axilla-Mgt-ASCO-2021-v3-cover-800px-300x471.png)
Axilla Management in Early-Stage Breast Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2021/04/ASCO-Obese-Dosing-cover-800px-300x512.png)
Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2021/04/ASCO-Salivary-Gland-cover-800px-300x512.png)
Management of Salivary Gland Malignancy
![](https://www.guidelinecentral.com/wp-content/uploads/2021/02/ASCO-Dyspnea-2020-v3a-cover-800px-300x512.png)
Management of Dyspnea in Advanced Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2021/03/ASCO-Naso-Ca-cover-800px-300x512.png)
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma
![](https://www.guidelinecentral.com/wp-content/uploads/2020/10/ASCO-Femur-cover-800px-300x512.png)
Treatment of Metastatic Carcinoma and Myeloma of the Femur
![](https://www.guidelinecentral.com/wp-content/uploads/2020/07/ASCO-Neuropathy-cover-800px-300x512.png)
Prevention And Management Of Chemotherapy-Induced Peripheral Neuropathy In Survivors Of Adult Cancers
![](https://www.guidelinecentral.com/wp-content/uploads/2020/04/ASCO-SCC-Primary-Head-Neck-cover-800px-300x471.png)
Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck
![](https://www.guidelinecentral.com/wp-content/uploads/2021/12/ASCO-Germline-Ovarian-cover-800px-300x512.png)
Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2020/01/ASCO-Prostate-Imaging-cover-800px-300x512.png)
Optimum Imaging Strategies for Advanced Prostate Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2020/01/ASCO-ER-PgR-cover-800px-300x471.png)
Estrogen and Progesterone Receptor Testing in Breast Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2019/12/ASCO-Prostate-Biomarkers-cover-800px-300x512.png)
Molecular Biomarkers in Localized Prostate Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2019/12/ASCO-Lunc-Ca-Surveillance-cover-800px-300x512.png)
Lung Cancer Surveillance After Definitive Curative-Intent Therapy
![](https://www.guidelinecentral.com/wp-content/uploads/2019/07/ASCO-MRONJ-cover-800px-300x471.png)
Medication-Related Osteonecrosis of the Jaw
![](https://www.guidelinecentral.com/wp-content/uploads/2019/06/ASCO-Pancreatic-Ca-PC-cover-800px-300x512.png)
Potentially Curable Pancreatic Adenocarcinoma
![](https://www.guidelinecentral.com/wp-content/uploads/2019/04/ASCO-Colon-Adjuvant-v3a-cover-800px-300x512.png)
Adjuvant Therapy for Stage III Colon Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2019/06/ASCO-ESA-cover-800px-300x512.png)
Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents
![](https://www.guidelinecentral.com/wp-content/uploads/2019/02/ASCO-Neck-SCC-cover-800px-300x471.png)
Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx
![](https://www.guidelinecentral.com/wp-content/uploads/2019/02/ASCO-CRC-Tx-cover-800px-300x471.png)
Treatment of Early-Stage Colorectal Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2018/11/ASCO-HR-Adjuvant-2018-Update-cover800px-300x512.png)
Hormone Receptor–Positive Breast Cancer Adjuvant Endocrine Therapy
![](https://www.guidelinecentral.com/wp-content/uploads/2018/11/ASCO-Pancreatic-Susceptibility-cover-800px-300x512.png)
Pancreatic Cancer - Evaluating Susceptibility
![](https://www.guidelinecentral.com/wp-content/uploads/2018/09/ASCO-Prophylaxis-cover-800px-300x512.png)
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression
![](https://www.guidelinecentral.com/wp-content/uploads/2018/05/ASCO-Palliative-cover-800px-300x512.png)
Palliative Care in the Global Setting
![](https://www.guidelinecentral.com/wp-content/uploads/2018/02/ASCO-FN-cover-800px-300x512.png)
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy
![](https://www.guidelinecentral.com/wp-content/uploads/2018/01/ASCO-BMA-in-MM-cover-800px-300x512.png)
Bone-Modifying Agents in Multiple Myeloma
![](https://www.guidelinecentral.com/wp-content/uploads/2017/10/ASCO-BMA-Breast-update-cover-800px-300x512.png)
Bone-Modifying Agents in Metastatic Breast Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2017/04/ASCO-CRPC-cover-800px-300x512.png)
Chemotherapy-Naïve Castration-Resistant Prostate Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2017/02/ASCO-Colorectal-Biomarkers-cover-800px-300x512.png)
Colorectal Cancer Biomarkers
![](https://www.guidelinecentral.com/wp-content/uploads/2016/08/Ovarian-Ca-cover-800px-300x512.png)
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer
![](https://www.guidelinecentral.com/wp-content/uploads/2016/07/ASCO-Pain-After-Cancer-cover-800-px-300x471.png)
Chronic Pain in Survivors of Adult Cancers
![](https://www.guidelinecentral.com/wp-content/uploads/2016/12/Cardiac-Dys-cover-800px-300x512.png)